Iranian Society of Gynecology Oncology

Authors

1 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

2 Tehran University of Medical Sciences, Tehran, Iran

Abstract

Introduction: When a mother is contaminated with the parasitic protozoan Toxoplasma gondii as a primary infection in pregnancy, the golden test to confirm fetus infection is polymerase chain reaction (PCR), for the parasite DNA in amniotic fluid that may reach fetus and cause congenital toxoplasmosis. Toxoplasmosis sometimes appears with very rare presentations that should be considered and treated to save mother and her baby.
Case Presentation: A 28-year-old pregnant mother was referred to the perinatology clinic of Shariati hospital, Tehran, Iran, for the diagnosis of her fetus problem. She was a rare case of congenital toxoplasmosis.
Conclusions: Diagnosis of toxoplasmosis in pregnancy is based on seroconversion of antibodies; based on many studies in the literature, the best method to confirm fetus is PCR for Toxoplasma gondii DNA in amniotic fluid.

Keywords

  1. Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc Ser C Appl Stat. 2005;54(2):385-404. [DOI:10.1111/j.1467-9876.2005.00490.x]
  2. Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc Ser C Appl Stat. 2005;54(2):385-404. [DOI:10.1111/j.1467-9876.2005.00490.x]
  3. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321(7254):142-7. [DOI:10.1136/bmj.321.7254.142] [PMID]
  4. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321(7254):142-7. [DOI:10.1136/bmj.321.7254.142] [PMID]
  5. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. J Med Screen. 2002;9(3):135-41. [DOI:10.1136/jms.9.3.135] [PMID]
  6. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. J Med Screen. 2002;9(3):135-41. [DOI:10.1136/jms.9.3.135] [PMID]
  7. Portela RW, Bethony J, Costa MI, Gazzinelli A, Vitor RW, Hermeto FM, et al. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of lycoinositolphospholipid-specific immunoglobulin A. J Infect Dis. 2004;190(1):175-83. [DOI:10.1086/421505] [PMID]
  8. Portela RW, Bethony J, Costa MI, Gazzinelli A, Vitor RW, Hermeto FM, et al. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of lycoinositolphospholipid-specific immunoglobulin A. J Infect Dis. 2004;190(1):175-83. [DOI:10.1086/421505] [PMID]
  9. Binquet C, Wallon M, Quantin C, Gadreau M, Peyron F. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies]. Rev Epidemiol Sante Publique. 2002;50(5):475-87.
  10. Binquet C, Wallon M, Quantin C, Gadreau M, Peyron F. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies]. Rev Epidemiol Sante Publique. 2002;50(5):475-87.
  11. Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, Semprini AE, et al. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG. 2005;112(1):31-7. [DOI:10.1111/j.1471-0528.2004.00299.x] [PMID]
  12. Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, Semprini AE, et al. Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG. 2005;112(1):31-7. [DOI:10.1111/j.1471-0528.2004.00299.x] [PMID]
  13. Hohlfeld P, MacAleese J, Capella-Pavlovski M, Giovangrandi Y, Thulliez P, Forestier F, et al. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol. 1991;1(4):241-4. [DOI:10.1046/j.1469-0705.1991.01040241.x] [PMID]
  14. Hohlfeld P, MacAleese J, Capella-Pavlovski M, Giovangrandi Y, Thulliez P, Forestier F, et al. Fetal toxoplasmosis: ultrasonographic signs. Ultrasound Obstet Gynecol. 1991;1(4):241-4. [DOI:10.1046/j.1469-0705.1991.01040241.x] [PMID]
  15. Gilbert R, Gras L, European Multicentre Study on Congenital T. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 2003;110(2):112-20. https://doi.org/10.1046/j.1471-0528.2003.02325.x [DOI:10.1016/S1470-0328(02)02325-X] [PMID]
  16. Gilbert R, Gras L, European Multicentre Study on Congenital T. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG. 2003;110(2):112-20. https://doi.org/10.1046/j.1471-0528.2003.02325.x [DOI:10.1016/S1470-0328(02)02325-X] [PMID]
  17. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG. 2005;112(5):567-74. [DOI:10.1111/j.1471-0528.2005.00486.x] [PMID]
  18. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, et al. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG. 2005;112(5):567-74. [DOI:10.1111/j.1471-0528.2005.00486.x] [PMID]
  19. Gollub EL, Leroy V, Gilbert R, Chene G, Wallon M, European Toxoprevention Study G. Effectiveness of health education on Toxoplasma related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):137-45. [DOI:10.1016/j.ejogrb.2007.09.010] [PMID]
  20. Gollub EL, Leroy V, Gilbert R, Chene G, Wallon M, European Toxoprevention Study G. Effectiveness of health education on Toxoplasma related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):137-45. [DOI:10.1016/j.ejogrb.2007.09.010] [PMID]
  21. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol. 1999;180(2 Pt 1):410-5. [DOI:10.1016/S0002-9378(99)70224-3]
  22. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol. 1999;180(2 Pt 1):410-5. [DOI:10.1016/S0002-9378(99)70224-3]